Parkinson disease trials in Austria

In Austria 12 Also abroad 823

12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
Where
Innsbruck, Linz, Vienna
Age
40 years to 85 years
People
474 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07781644 · EU 2025-524064-37-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Where
Graz, Innsbruck, Linz, Vienna
Age
50 years to 85 years
People
900 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07174310 · EU 2025-522683-32-00
Phase 2/3Taking people
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Where
Innsbruck, Salzburg
Age
40 years to 80 years
People
550 worldwide
Run by
Biohaven Therapeutics Ltd.
See details and how to joinNCT06976268 · EU 2025-521113-13-00
Phase 1Taking people
A study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s disease.
Where
Innsbruck
Age
18 years and over
People
150 worldwide
Run by
F. Hoffmann-La Roche AG
See details and how to join2024-511110-21-00 · EU 2024-511110-21-00
No phaseTaking people
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Where
Innsbruck
Age
18 years and over
People
1,500 worldwide
Run by
Boston Scientific Corporation
See details and how to joinNCT02071134
No phaseTaking people
Real-world Patient Experiences With Inbrija®
Where
Altmünster, Graz
Age
18 years and over
People
120
Run by
Merz Therapeutics GmbH
See details and how to joinNCT07797790
Phase 1Taking people
Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease
Where
Wien
Age
40 years to 75 years
People
36 worldwide
Run by
Tridem Bioscience FlexCo
See details and how to joinNCT07840027 · EU 2024-519123-14-00
Phase 1Taking people
An Unblinded, Single Arm, Pilot Observational Study to Test the Safety, Tolerability, Immunogenicity and the Biological Effects of TRB-001 Vaccination.
Where
Vienna
Age
18 years and over
People
6
Run by
Tridem Bioscience FlexCo
See details and how to joinNCT07777484 · EU 2026-526294-42-00
No phaseTaking people
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Where
Innsbruck
Age
30 years and over
People
4,500 worldwide
Run by
Michael J. Fox Foundation for Parkinson's Research
See details and how to joinNCT04477785
No phaseTaking people
Observational Study on "Functional Overlay" in Patients With Movement Disorders
Where
Graz
Age
18 years to 18 years
People
216
Run by
Medical University of Graz
See details and how to joinNCT05943652
No phaseTaking people
Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease
Where
Graz
Age
18 years and over
People
2,000 worldwide
Run by
AbbVie
See details and how to joinNCT06937034
No phaseTaking people
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
Where
Innsbruck
Age
18 years and over
People
350 worldwide
Run by
Kliniken Beelitz GmbH
See details and how to joinNCT04706234